Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer
- PMID: 9653485
- DOI: 10.1023/a:1008276223400
Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer
Comment on
-
Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer.Ann Oncol. 1998 May;9(5):505-9. doi: 10.1023/a:1008282412670. Ann Oncol. 1998. PMID: 9653491 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
